Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Good
|
New words:
Antipsychotic, Apotex, Armitage, Axid, boxed, CATIE, Circuit, communicating, confidential, Dau, delivery, depreciated, earliest, Eli, ELSI, escrow, extend, extendible, faster, finance, gain, gathering, glucose, indirect, inquiry, Intervention, irrelevant, joined, label, lipid, master, mature, maturity, Mental, metabolism, monthly, National, Novopharm, omitted, Ortiz, parent, pen, pharmacy, responding, restitution, retirement, Robert, schizophrenia, showed, significantly, statistically, study, subsidiary, suicidal, superior, system, Tringali, uncommon, unconditionally, violative, working
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 10.1 the Eli Lilly and Company Bonus Plan, As Amended
- 10.2 Master Settlement Agreement
- 11 Statement Re: Computation of Earnings (Loss) Per Share
- 12 Statement Re: Computation of Ratio of Earnings
- 31.1 Rule 13A-14(A) Certification of Sidney Taurel
- 31.2 Rule 13A-14(A) Certification of Charles E. Golden
- 32 Section 1350 Certification
- 99 Cautionary Statement
Related press release
LLY similar filings
Filing view
External links